Topline Capital Management LLC Invests $16.95 Million in Paysign, Inc. (NASDAQ:PAYS)

Topline Capital Management LLC acquired a new position in shares of Paysign, Inc. (NASDAQ:PAYS - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 5,611,128 shares of the company's stock, valued at approximately $16,946,000. Paysign accounts for 3.2% of Topline Capital Management LLC's investment portfolio, making the stock its 10th biggest position. Topline Capital Management LLC owned about 10.48% of Paysign as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Wells Fargo & Company MN increased its holdings in shares of Paysign by 51.7% during the fourth quarter. Wells Fargo & Company MN now owns 15,385 shares of the company's stock valued at $46,000 after acquiring an additional 5,243 shares in the last quarter. SG Americas Securities LLC boosted its stake in shares of Paysign by 33.5% during the 4th quarter. SG Americas Securities LLC now owns 15,508 shares of the company's stock worth $47,000 after acquiring an additional 3,895 shares in the last quarter. Virtu Financial LLC acquired a new stake in Paysign in the 4th quarter valued at $78,000. Bard Associates Inc. boosted its holdings in Paysign by 19.7% in the 4th quarter. Bard Associates Inc. now owns 33,450 shares of the company's stock worth $101,000 after buying an additional 5,497 shares during the last quarter. Finally, Rhumbline Advisers lifted its holdings in Paysign by 13.7% in the 4th quarter. Rhumbline Advisers now owns 44,284 shares of the company's stock valued at $134,000 after purchasing an additional 5,339 shares in the last quarter. 25.89% of the stock is currently owned by institutional investors.

Insider Transactions at Paysign

In other news, CEO Mark Newcomer sold 100,000 shares of the company's stock in a transaction on Monday, February 24th. The shares were sold at an average price of $2.73, for a total transaction of $273,000.00. Following the completion of the transaction, the chief executive officer now directly owns 8,936,886 shares in the company, valued at approximately $24,397,698.78. This represents a 1.11 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 22.40% of the stock is currently owned by corporate insiders.

Paysign Stock Performance

Shares of Paysign stock traded up $0.04 on Tuesday, reaching $2.36. The stock had a trading volume of 119,116 shares, compared to its average volume of 257,679. The business's 50-day moving average price is $2.32 and its two-hundred day moving average price is $2.91. Paysign, Inc. has a fifty-two week low of $1.80 and a fifty-two week high of $5.59. The stock has a market cap of $126.85 million, a P/E ratio of 15.73 and a beta of 0.77.

Paysign (NASDAQ:PAYS - Get Free Report) last announced its quarterly earnings data on Tuesday, March 25th. The company reported $0.02 earnings per share for the quarter, hitting the consensus estimate of $0.02. The firm had revenue of $15.61 million during the quarter, compared to analysts' expectations of $15.42 million. Paysign had a return on equity of 30.64% and a net margin of 14.28%. As a group, equities analysts forecast that Paysign, Inc. will post 0.21 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have commented on PAYS shares. DA Davidson restated a "buy" rating and set a $6.00 price target on shares of Paysign in a research note on Wednesday, March 26th. Barrington Research reissued an "outperform" rating and set a $7.00 price objective on shares of Paysign in a research report on Wednesday, March 26th.

Paysign Company Profile

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.